Sunny Zhou
Professor Northeastern University
Professor Zhou’s laboratory (aka SunnyLand) applies protein chemistry, analysis and engineering to biology and medicine. One program is “Hybrid Modality Engineering of Proteins”—a platform to introduce non-canonical chemical moieties and/or scaffolds into peptides and proteins to confer novel functions otherwise unavailable, such as photomedicine. Over the past two decades, Sunny has been actively collaborating and consulting with over 20 biopharma companies worldwide. Since 2020, he has been a co-founder and advisor of NIRa Biosciences (now part of Alys Pharmaceuticals).
Seminars
Wednesday 10th June 2026
Examining Photomedicine ADCs: Spatial & Temporal Photo-Activation
3:30 pm
- Overview of the advantages of photomedicine
- Explore photo-cleavable linkers for spatial and temporal activation
- Related topic on photodynamic therapy (PDT), i.e., photosensitizer-antibody conjugate (PAC)
Thursday 11th June 2026
Examining Photomedicine ADCs: Spatial & Temporal Photo-Activation
12:00 pm
- Overview the advantages of photomedicine
- Explore photo-cleavable linkers for spatial andtemporal activation
- Discuss the related topic on photodynamic therapy (PDT), i.e., photosensitizer-antibody conjugate (PAC)
Tuesday 9th June 2026
Comparing Site-Specific, Homogeneous, Enzymatic & Chemical Conjugation & Their Individual Advantages & Potential in Improving ADC Stability & Efficacy
2:15 pm
- Comparing reproducibility and DAR control of each conjugation strategy to select the ideal one for your ADC
- Discussing the advantages of each method in improving stability and scalability
- Assessing implications of each method on ADC performance
